Episode 068: Breast Cancer Series, Pt. 13- Metastatic Triple Negative Breast Cancer
The Fellow on Call: The Heme/Onc Podcast
00:00
Advancements in Metastatic TNBC Treatment
This chapter explores the evolution of treatment strategies for metastatic triple-negative breast cancer (TNBC), from early chemotherapy to the inclusion of immunotherapy. It highlights significant clinical trials and the impact of genetic factors like BRCA mutations on treatment efficacy, as well as the importance of CPS scores in determining therapy regimens. The discussion underlines the need for ongoing research and trial validation to refine and optimize patient care.
Transcript
Play full episode
